Table 1. Association of BRAF mutation status with clinicopathological parameters.

Characteristic	Rate Mutant	Mutant	Wild type	p-value1
All patients	38.7%	169	268
Gender				0.844
Male	39.3%	90	139
Female	38.0%	79	129
Age				<0.001
<50 years	53.4%	70	61
50–59 years	39.3%	42	65
60–69 years	35.7%	41	74
≥70 years	19.0%	16	68
Ulceration				0.338
Yes	45.7%	21	25
No	37.9%	148	243
Tumor thickness				0.190
≤0.50 mm	30.2%	29	67
0.51–0.75 mm	33.0%	30	61
0.76–1.00 mm	46.2%	24	28
1.01–2.00 mm	43.8%	60	77
2.01–4.00 mm	42.2%	19	26
>4.00 mm	43.8%	7	9
Histological subtype				<0.001
SSM	43.0%	141	187
NM	57.7%	15	11
LMM	5.8%	3	49
ALM	30.0%	9	21
Clark level				0.277
I–III	36.2%	88	155
IV or V	41.8%	81	113
Mitoses/mm2				0.038
<1	33.2%	72	145
≥1	43.0%	93	123

¹p-values are results of Chi-square tests.